glp-1 medication insurance coverage MCT2D Ro launches GLP-1 insurance coverage
Description
3 Participants on oral semaglutide lost an average of about 16.6% of their body weight
J Endocrinol 222: 191200
Insurance not accepted (true of all compounded GLP-1 coverage)
While not directly linked to Mounjaro, changes in immune function or systemic health while on the medication could increase susceptibility to infections or inflammation
Members who continue with the program and report results are likely those experiencing positive outcomes - people who discontinue treatment or are dissatisfied are less likely to continue reporting data
P.TcitoL
